SHINGRIX Safety Information:

Contraindications
Hypersensitivity to the active substances or to any component of the vaccine.

Undesirable effects
Very common: headache, gastrointestinal symptoms (including nausea, vomiting, diarrhea, and/or abdominal pain), myalgia, injection site reactions (such as pain, redness, swelling), fatigue, chills, and fever.
Common: injection site pruritus, malaise.

For more information, please refer to the prescribing information or contact GlaxoSmithKline: P.O Box 58589, Jeddah, 21544, Kingdom of Saudi Arabia. Telephone: +966 12 653 6666 or via gcc.medinfo@gsk.com

To report Adverse Event(s) associated with the use of GSK product(s), please contact us via saudi.safety@gsk.com

To report Quality related product complaint(s) associated with the use of GSK product(s), please contact us via ksa.productqualitycomplaints@gsk.com

For healthcare professional in Saudi Arabia only.

©2025 GSK group of companies or its licensor.

Trademarks are owned by or licensed to the GSK group of companies.

GSK does not recommend, endorse, or accept liability for sites controlled by a third party.

GSK is not responsible for third-party content.

PM-SA-SGX-STBD-250001 – Oct 2025